期刊文献+

A Subchronic Toxicity Study on Lactobacillus Fermentum GM 090 in Rat 被引量:1

A Subchronic Toxicity Study on Lactobacillus Fermentum GM 090 in Rat
下载PDF
导出
摘要 Lactobacillus fermentum (L. fermentum) is one of seven species in the genus Lactobacillus[1]. With a long history of safe use in fermented food production, Lactobacillus is considered as one of the most beneficial probiotics[23]. The most well-known potential health benefit is improving digestion and immune function[4.s]. Other beneficial functions of Lactobacillus strains include managing lactose intoleranceIs], lowering cholesterol and blood pressureIs], reducing inflammation[~], and prevention of cancerIs'7]. L. fermentum is usually found during malt whisky fermentation]8]. L. fermentum CP34 was found to have the significant effect of decreasing the serum antigen-specific IgE levels compared to a control group[9]. Lactobacillus fermentum (L. fermentum) is one of seven species in the genus Lactobacillus[1]. With a long history of safe use in fermented food production, Lactobacillus is considered as one of the most beneficial probiotics[23]. The most well-known potential health benefit is improving digestion and immune function[4.s]. Other beneficial functions of Lactobacillus strains include managing lactose intoleranceIs], lowering cholesterol and blood pressureIs], reducing inflammation[~], and prevention of cancerIs'7]. L. fermentum is usually found during malt whisky fermentation]8]. L. fermentum CP34 was found to have the significant effect of decreasing the serum antigen-specific IgE levels compared to a control group[9].
出处 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2013年第8期680-683,共4页 生物医学与环境科学(英文版)
基金 supported by the National Scienceand technology support program(2012BAK01B04)
  • 相关文献

参考文献17

  • 1Felis GE, Dellaglio F. Taxonomy of Lactobacilli and Bifidobacteria. Curro Issues Intestinal Microbiol, 2007; 8, 44-61.
  • 2Yoon KY, Woodams EE, Hang YD. Probiotication of Tomato Juice by Lactic Acid Bacteria. J Microbiol, 2004; 42, 315-8.
  • 3Fuller R. History and development of probiotics. In: Probiotics-The Scientific Basis. Champman and Hall (Fuller R. ed.), 1992; 1-18. London.
  • 4Park SY, Ji GE, Ko YT, et al. Potentiation of hydrogen peroxide, nitric oxide and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int J Food Microbiol, 1999; 46, 231-41.
  • 5Sanders ME. Considerations for use of probiotic bacteria to modulate human health. J Nutr, 2000; 130, 3845-905.
  • 6Reid G, Jass J, Sebulsky MT, et al. Potential uses of probiotics in clinical practice. Clin Microbiol, 2003; 16 (4), 658-72.
  • 7Salminen 5, Deghton M, Gorbach S(1974). Lactic acid bacteria in health and disease. In: Lactic Acid Bacteria. Marcel Dekker Inc (Salminen S. eds.), pp. 199-226. NY.
  • 8van Beek 5, Pries FG. Evolution of the lactic acid bacterial community during malt whisky fermentation: a polyphasic study. Appl Environ Microbiol, 2002; 68(1), 297-305.
  • 9Ishida Y, Bandou I, Kanzato H. Decrease in ovalbumin specific IgE of mice serum after oral uptake of lactic acid bacteria. Biosci Biotechnol Biochem, 2003; 67(5), 951-7.
  • 10Donohue DC, Salminen s. Safety of probiotic bacteria. Asia Pac J Clin Nutr, 1996; 5, 2S-8.

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部